These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2260855)

  • 1. Elevated soluble interleukin-2 receptor levels in patients with active multiple sclerosis.
    Adachi K; Kumamoto T; Araki S
    Ann Neurol; 1990 Nov; 28(5):687-91. PubMed ID: 2260855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Soluble interleukin-2 receptor and soluble CD8 molecules in cerebrospinal fluid and serum of patients with multiple sclerosis.
    Carrieri PB; Soscia E; Iacovitti B; Pellicano M; D'Antonio A; Provitera V; Perrella O
    Eur Cytokine Netw; 1992; 3(5):495-8. PubMed ID: 1477299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders.
    Kittur SD; Kittur DS; Soncrant TT; Rapoport SI; Tourtellotte WW; Nagel JE; Adler WH
    Ann Neurol; 1990 Aug; 28(2):168-73. PubMed ID: 2221845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum levels of soluble interleukin-2 receptor in patients with localized scleroderma.
    Ihn H; Sato S; Fujimoto M; Kikuchi K; Takehara K
    Br J Dermatol; 1996 May; 134(5):843-7. PubMed ID: 8736323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of myelin basic protein in cerebrospinal fluid.
    Ohta M; Ohta K
    Expert Rev Mol Diagn; 2002 Nov; 2(6):627-33. PubMed ID: 12465458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The serum levels of soluble interleukin-2 receptor in patients with malignant lymphocytic proliferative disorders].
    Xu J; Wang B
    Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):82-4. PubMed ID: 10921108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: IL-2 and sIL-2R levels in cerebrospinal fluid and serum. Review of literature and critical analysis of ELISA pitfalls.
    Sivieri S; Ferrarini AM; Gallo P
    Mult Scler; 1998 Feb; 4(1):7-11. PubMed ID: 9532585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
    Zailaie MZ
    Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyclosporine A on serum and urinary soluble interleukin-2 receptor in patients with lupus nephritis.
    Tang Z; Zhang J; Zhang S; Li L
    Chin Med J (Engl); 1997 Sep; 110(9):686-9. PubMed ID: 9642325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The changes of soluble interleukin-2 receptor in serum and cerebrospinal fluid of patients with delayed encephalopathy after acute carbon monoxide poisoning].
    Gu R; Zhang X; Lu L; Lu H; Song J; Guo X; Zhang Z; Liu M
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2002 Oct; 20(5):350-2. PubMed ID: 14694723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical course and changes of soluble interleukin-2 receptor and soluble forms of intercellular adhesion molecule-1 (ICAM-1) in serum of multiple sclerosis patients].
    Bilińska M; Frydecka I; Podemski R
    Neurol Neurochir Pol; 2001; 35(1):47-56. PubMed ID: 11464716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis.
    Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D
    J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble interleukin-6 receptor (sIL-6R) in cerebrospinal fluid of patients with inflammatory and non inflammatory neurological diseases.
    Michalopoulou M; Nikolaou C; Tavernarakis A; Alexandri NM; Rentzos M; Chatzipanagiotou S; Cambouri C; Vassilopoulos D
    Immunol Lett; 2004 Jul; 94(3):183-9. PubMed ID: 15275965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes of serum interleukin 2 and soluble interleukin 2 receptor and their clinical significance in multiple myeloma].
    Wang Z; Li D; Yang J
    Zhonghua Zhong Liu Za Zhi; 1996 Nov; 18(6):439-41. PubMed ID: 9387297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
    Schmitt WH; Csernok E; Kobayashi S; Klinkenborg A; Reinhold-Keller E; Gross WL
    Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The level of soluble forms of interleukin-2 receptor and adhesive molecules ICAM-1 and VCAM-1 in platelets of multiple sclerosis patients].
    Bilińska M; Frydecka I; Podemski R
    Pol Merkur Lekarski; 1999 Jan; 6(31):23-6. PubMed ID: 10344149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-6 and sIL-6R concentration in the cerebrospinal fluid and serum of MS patients.
    Stelmasiak Z; Kozioł-Montewka M; Dobosz B; Rejdak K
    Med Sci Monit; 2001; 7(5):914-8. PubMed ID: 11535934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid levels of myelin basic protein-like material and soluble interleukin-2 receptor in multiple sclerosis.
    Fesenmeier JT; Whitaker JN; Herman PK; Walker DP
    J Neuroimmunol; 1991 Oct; 34(1):77-80. PubMed ID: 1716642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of serum soluble interleukin-2 receptor level in patients with non-Hodgkin's lymphoma].
    Shimomura Y; Tsurumi H; Sawada M; Yamada T; Hara T; Fukuno K; Goto H; Moriwaki H
    Rinsho Ketsueki; 1999 Aug; 40(8):639-45. PubMed ID: 10496038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.